It is the cache of ${baseHref}. It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

Churg–Strauss syndrome associated with antiphospholipid antibodi
skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

14804

Churg–Strauss syndrome associated with antiphospholipid antibodies in a patient with recurrent myocardial and cerebral ischemia



Case report

(2483) Total Article Views


Authors: Paroli M, Polidoro A, Romano S, Accapezzato D

Published Date November 2012 Volume 2012:5 Pages 79 - 81
DOI: http://dx.doi.org/10.2147/IMCRJ.S37516

Marino Paroli,1 Alessandro Polidoro,1 Simone Romano,1 Daniele Accapezzato2

1Department of Biotechnology and Medical-Surgical Sciences, 2Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy

Abstract: We report on a case of Churg–Strauss syndrome (CSS) associated with the presence of antiphospholipid antibodies. The patient had a history of recurrent myocardial infarction and presented with acute ischemic cerebral disease. Eosinophilia with typical lung and skin lesions led us to diagnose the patient with CCS. We hypothesize that the presence of antiphospholipid antibodies significantly contributed to the ischemic events. We suggest that the search for antiphospholipid antibodies should be included in the laboratory work-up in CSS patients and patients affected by primary systemic vasculitides in general. Moreover, anticoagulant treatment appears to be warranted in all CSS patients and antiphospholipid antibodies to counteract this thrombosis-favoring association.

Keywords: Churg–Strauss syndrome, antiphospholipid antibodies, ischemic disease



Post to:
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter

 

Other articles by Dr Marino Paroli


Readers of this article also read: